Health & Biotech
ASX Health Stocks: Neurotech gets approval to treat children patients until they are 20 years old
ASX biotechs are looking up, and the FDA breakthroughs are starting to flow
ASX Health Stocks: Tissue Repair and Radiopharm jump double digits after US FDA meetings
Wellnex to buy leading Australian pain relief brand Pain Away for $22 million
ScoPo’s Powerplays: ASX health stocks fall as investors fail to reward good news
Check Up: Here’s how diabetes drugs can help you get off the beers and lose weight
ASX Health Stocks: Patrys, Immutep jump after reports show drugs well tolerated
ASX Health Stocks: 4DMedical makes breakthrough, potentially disrupts century-old method
Pop the champagne as EBR becomes latest ASX biotech to achieve key catalyst
PharmAust confirms safety of MPL, poised to up dosage in MND trial
Orphan drug designation has a direct impact on drug pricing for these pharma players
ScoPo’s Powerplays: ASX health stocks rise, Immutep surges 46pc on trial results
ASX Health Stocks: FDA approves Imugene’s Phase 1 trial; Noxopharm says it can fight skin disease
Weed Week: Cannabis helps chronic pain and insomnia, and here’s what the TGA rules say
ASX Health Stocks: Imugene’s liver cancer platform presented at prestigious conference
Incannex’s subsidiary to open multiple psychedelic clinics to capture wide open opportunity
ASX Health Stocks: Rhythym Bio skyrockets 70pc after being granted UK CA Mark
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
